191 related articles for article (PubMed ID: 17372854)
1. Severe infantile type of carnitine palmitoyltransferase II (CPT II) deficiency due to homozygous R503C mutation.
Spiegel R; Shaag A; Gutman A; Korman SH; Saada A; Elpeleg O; Shalev SA
J Inherit Metab Dis; 2007 Apr; 30(2):266. PubMed ID: 17372854
[TBL] [Abstract][Full Text] [Related]
2. Muscle Carnitine Palmitoyltransferase II (CPT II) Deficiency: A Conceptual Approach.
Joshi PR; Zierz S
Molecules; 2020 Apr; 25(8):. PubMed ID: 32295037
[TBL] [Abstract][Full Text] [Related]
3. Malignant hyperthermia-like syndrome and carnitine palmitoyltransferase II deficiency with heterozygous R503C mutation.
Hogan KJ; Vladutiu GD
Anesth Analg; 2009 Oct; 109(4):1070-2. PubMed ID: 19762733
[TBL] [Abstract][Full Text] [Related]
4. Carnitine palmitoyltransferase II (CPT II) deficiency responsible for refractory cardiac arrhythmias, acute multiorgan failure and early fatal outcome.
Serra G; Antona V; Insinga V; Morgante G; Vassallo A; Placa S; Piro E; Salerno S; Schierz IAM; Gitto E; Giuffrè M; Corsello G
Ital J Pediatr; 2024 Apr; 50(1):67. PubMed ID: 38616285
[TBL] [Abstract][Full Text] [Related]
5. Novel mutations associated with carnitine palmitoyltransferase II deficiency.
Taggart RT; Smail D; Apolito C; Vladutiu GD
Hum Mutat; 1999; 13(3):210-20. PubMed ID: 10090476
[TBL] [Abstract][Full Text] [Related]
6. A variable myopathy associated with heterozygosity for the R503C mutation in the carnitine palmitoyltransferase II gene.
Vladutiu GD; Bennett MJ; Smail D; Wong LJ; Taggart RT; Lindsley HB
Mol Genet Metab; 2000 Jun; 70(2):134-41. PubMed ID: 10873395
[TBL] [Abstract][Full Text] [Related]
7. Novel mutations in myopathic form of carnitine palmitoyltransferase II deficiency in a Chinese patient.
Cho SY; Siu TS; Ma O; Tam S; Lam CW
Clin Chim Acta; 2013 Oct; 425():125-7. PubMed ID: 23911907
[TBL] [Abstract][Full Text] [Related]
8. First Japanese Case of Carnitine Palmitoyltransferase II Deficiency with the Homozygous Point Mutation S113L.
Shima A; Yasuno T; Yamada K; Yamaguchi M; Kohno R; Yamaguchi S; Kido H; Fukuda H
Intern Med; 2016; 55(18):2659-61. PubMed ID: 27629963
[TBL] [Abstract][Full Text] [Related]
9. A novel mutation identified in carnitine palmitoyltransferase II deficiency.
Yang BZ; Ding JH; Roe D; Dewese T; Day DW; Roe CR
Mol Genet Metab; 1998 Feb; 63(2):110-5. PubMed ID: 9562964
[TBL] [Abstract][Full Text] [Related]
10. Carnitine palmitoyltransferase II (CPT II) deficiency: genotype-phenotype analysis of 50 patients.
Joshi PR; Deschauer M; Zierz S
J Neurol Sci; 2014 Mar; 338(1-2):107-11. PubMed ID: 24398345
[TBL] [Abstract][Full Text] [Related]
11. CPT2 gene mutations resulting in lethal neonatal or severe infantile carnitine palmitoyltransferase II deficiency.
Isackson PJ; Bennett MJ; Lichter-Konecki U; Willis M; Nyhan WL; Sutton VR; Tein I; Vladutiu GD
Mol Genet Metab; 2008 Aug; 94(4):422-427. PubMed ID: 18550408
[TBL] [Abstract][Full Text] [Related]
12. A novel mutation leading to the lethal form of carnitine palmitoyltransferase type-2 deficiency.
Dorum S; Güney Varal I; Gorukmez O; Dogan P; Ekici A
J Pediatr Endocrinol Metab; 2019 Jul; 32(7):781-783. PubMed ID: 31199774
[TBL] [Abstract][Full Text] [Related]
13. Identification of four novel mutations in patients with carnitine palmitoyltransferase II (CPT II) deficiency.
Yang BZ; Ding JH; Dewese T; Roe D; He G; Wilkinson J; Day DW; Demaugre F; Rabier D; Brivet M; Roe C
Mol Genet Metab; 1998 Aug; 64(4):229-36. PubMed ID: 9758712
[TBL] [Abstract][Full Text] [Related]
14. [CPT2 gene mutation analysis and prenatal diagnosis in a family with carnitine palmitoyltransferase II deficiency].
Tan JQ; Chen DY; Li WG; Li ZT; Huang JW; Yan TZ; Cai R
Zhongguo Dang Dai Er Ke Za Zhi; 2016 Dec; 18(12):1282-1285. PubMed ID: 27974123
[TBL] [Abstract][Full Text] [Related]
15. Carnitine palmitoyltransferase II deficiency: a clinical, biochemical, and molecular review.
Sigauke E; Rakheja D; Kitson K; Bennett MJ
Lab Invest; 2003 Nov; 83(11):1543-54. PubMed ID: 14615409
[TBL] [Abstract][Full Text] [Related]
16. Cause of recurrent rhabdomyolysis, carnitine palmitoyltransferase II deficiency and novel pathogenic mutation.
Çakar NE; Gör Z; Yeşil G
Ideggyogy Sz; 2021 Mar; 74(3-4):135-138. PubMed ID: 33938664
[TBL] [Abstract][Full Text] [Related]
17. Abbreviated half-lives and impaired fuel utilization in carnitine palmitoyltransferase II variant fibroblasts.
Yao M; Cai M; Yao D; Xu X; Yang R; Li Y; Zhang Y; Kido H; Yao D
PLoS One; 2015; 10(3):e0119936. PubMed ID: 25781464
[TBL] [Abstract][Full Text] [Related]
18. Mutation and biochemical analysis in carnitine palmitoyltransferase type II (CPT II) deficiency.
Olpin SE; Afifi A; Clark S; Manning NJ; Bonham JR; Dalton A; Leonard JV; Land JM; Andresen BS; Morris AA; Muntoni F; Turnbull D; Pourfarzam M; Rahman S; Pollitt RJ
J Inherit Metab Dis; 2003; 26(6):543-57. PubMed ID: 14605500
[TBL] [Abstract][Full Text] [Related]
19. Fluxomic assay-assisted diagnosis orientation in a cohort of 11 patients with myopathic form of CPT2 deficiency.
Fontaine M; Kim I; Dessein AF; Mention-Mulliez K; Dobbelaere D; Douillard C; Sole G; Schiff M; Jaussaud R; Espil-Taris C; Boutron A; Wuyts W; Acquaviva C; Vianey-Saban C; Roland D; Joncquel-Chevalier Curt M; Vamecq J
Mol Genet Metab; 2018 Apr; 123(4):441-448. PubMed ID: 29478820
[TBL] [Abstract][Full Text] [Related]
20. [Molecular analysis of a patient with carnitine palmitoyltransferase II deficiency].
Akanuma J; Wataya K; Matubara Y; Yamamoto T; Kira J; Narisawa K
Rinsho Shinkeigaku; 1997 Jun; 37(6):532-5. PubMed ID: 9366186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
